相关实验视频

Updated: Jul 28, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

复发性/耐药性扩散性大B细胞淋巴瘤患者的PD-1单克隆抗体含疗程的多奥米克分析和响应预测

Xinrui Chen1, Yan Qin2, Xuemin Xue3

  • 1Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.

Cancer immunology, immunotherapy : CII
|October 2, 2024
PubMed
概括

预测复发性/耐药性扩散性大B细胞淋巴瘤 (DLBCL) 的治疗反应至关重要. 一个结合临床,基因组和免疫细胞数据的人工神经网络模型准确地预测了患者对PD-1抗体和rituximab疗法的反应.

关键词:
人工神经网络的人工神经网络扩散大的B细胞淋巴瘤.免疫治疗是一种免疫疗法.多个omics的分析分析.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...